Rose M. Cubbon

1.6k total citations
10 papers, 742 citations indexed

About

Rose M. Cubbon is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Rose M. Cubbon has authored 10 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Rose M. Cubbon's work include Lipoproteins and Cardiovascular Health (3 papers), Melanoma and MAPK Pathways (3 papers) and Synthesis and biological activity (2 papers). Rose M. Cubbon is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Melanoma and MAPK Pathways (3 papers) and Synthesis and biological activity (2 papers). Rose M. Cubbon collaborates with scholars based in United States, Italy and United Kingdom. Rose M. Cubbon's co-authors include Richard Cummings, Linda S. Wicker, James E. Thompson, Patricia M. Cameron, Robert A. Frankshun, Peter T. Meinke, Nigel J. Liverton, Barry R. Cunningham, Julie A. DeMartino and Ayesha Sitlani and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Lipid Research.

In The Last Decade

Rose M. Cubbon

10 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose M. Cubbon United States 9 290 254 237 148 75 10 742
Kévin Ly Canada 11 246 0.8× 218 0.9× 119 0.5× 74 0.5× 27 0.4× 20 530
SM Watt United Kingdom 13 76 0.3× 394 1.6× 369 1.6× 179 1.2× 48 0.6× 20 1.1k
Antoine Désilets Canada 18 51 0.2× 303 1.2× 87 0.4× 120 0.8× 31 0.4× 35 768
Cenap Güngör Germany 19 130 0.4× 544 2.1× 145 0.6× 393 2.7× 80 1.1× 51 941
François Ringeisen France 14 85 0.3× 517 2.0× 72 0.3× 373 2.5× 38 0.5× 33 899
Elizabeth Liniker Australia 10 90 0.3× 377 1.5× 243 1.0× 566 3.8× 68 0.9× 17 1.1k
Willem‐Jan Keune United Kingdom 17 174 0.6× 704 2.8× 93 0.4× 209 1.4× 12 0.2× 20 1.1k
Carlos A. Castañeda Peru 15 93 0.3× 286 1.1× 162 0.7× 461 3.1× 55 0.7× 66 893
Adam Giermasz Poland 20 144 0.5× 387 1.5× 213 0.9× 401 2.7× 21 0.3× 56 1.1k

Countries citing papers authored by Rose M. Cubbon

Since Specialization
Citations

This map shows the geographic impact of Rose M. Cubbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose M. Cubbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose M. Cubbon more than expected).

Fields of papers citing papers by Rose M. Cubbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose M. Cubbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose M. Cubbon. The network helps show where Rose M. Cubbon may publish in the future.

Co-authorship network of co-authors of Rose M. Cubbon

This figure shows the co-authorship network connecting the top 25 collaborators of Rose M. Cubbon. A scholar is included among the top collaborators of Rose M. Cubbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose M. Cubbon. Rose M. Cubbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nimonkar, Amitabh V., Kevin Godbout, Rose M. Cubbon, et al.. (2019). A lipoprotein lipase–GPI-anchored high-density lipoprotein–binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome. Journal of Biological Chemistry. 295(10). 2900–2912. 16 indexed citations
2.
Lin, Songnian, Lihu Yang, Sander G. Mills, et al.. (2015). Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 25(22). 5402–5408. 9 indexed citations
3.
Lin, Songnian, Jeffrey J. Hale, Sander G. Mills, et al.. (2009). Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 19(12). 3238–3242. 18 indexed citations
4.
Bottomley, Matthew J., Agostino Cirillo, Laura Orsatti, et al.. (2008). Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants. Journal of Biological Chemistry. 284(2). 1313–1323. 107 indexed citations
5.
Pandit, Shilpa, Joseph C. Santoro, Sookhee Ha, et al.. (2008). Functional analysis of sites within PCSK9 responsible for hypercholesterolemia. Journal of Lipid Research. 49(6). 1333–1343. 35 indexed citations
6.
Fisher, Timothy S., Paola Lo Surdo, Shilpa Pandit, et al.. (2007). Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation. Journal of Biological Chemistry. 282(28). 20502–20512. 159 indexed citations
7.
Thompson, James E., Rose M. Cubbon, Richard Cummings, et al.. (2002). Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(8). 1219–1223. 224 indexed citations
8.
Podolin, Patricia L., Rose M. Cubbon, Utpal B. Pajvani, et al.. (2000). DIFFERENTIAL GLYCOSYLATION OF INTERLEUKIN 2, THE MOLECULAR BASIS FOR THE NOD Idd3 TYPE 1 DIABETES GENE?. Cytokine. 12(5). 477–482. 58 indexed citations
9.
Jones, A. Brian, John J. Acton, Richard Cummings, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate. Bioorganic & Medicinal Chemistry Letters. 9(14). 2109–2114. 3 indexed citations
10.
Hill, Christopher M., K. Wayne Marshall, John P. Mayer, et al.. (1994). Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.. The Journal of Immunology. 152(6). 2890–2898. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kévin Ly Breakdown of academic impact, for papers by SM Watt Breakdown of academic impact, for papers by Antoine Désilets Breakdown of academic impact, for papers by Cenap Güngör Breakdown of academic impact, for papers by François Ringeisen Breakdown of academic impact, for papers by Elizabeth Liniker Breakdown of academic impact, for papers by Willem‐Jan Keune Breakdown of academic impact, for papers by Carlos A. Castañeda Breakdown of academic impact, for papers by Adam Giermasz
Rankless by CCL
2026